Company / Operating Income per Share
Anika Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.77
FY2025
5-year range
-$1.96 / $2.39
FY2021-FY2025
Trend
-120.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-1.96 in FY2022 to $4.09 in FY2016.
Based on SEC 10-K filings.
-0.77 in FY2025.
Declined from $0.06 to $-0.77 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 120.3% year-over-year.
- Peak operating income per share was recorded in FY2016.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.77 | -120.3% |
| FY2024 | -$0.35 | -702.9% |
| FY2023 | $0.06 | +102.9% |
| FY2022 | -$1.96 | -182.1% |
| FY2021 | $2.39 | +57.2% |
| FY2020 | $1.52 | -52.8% |
| FY2019 | $3.22 | -6.6% |
| FY2018 | $3.45 | +4.7% |
| FY2017 | $3.29 | -19.5% |
| FY2016 | $4.09 | +86.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026